• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶适配体识别:一种揭示的歧义。

Thrombin-aptamer recognition: a revealed ambiguity.

机构信息

Università di Napoli Federico II, Via Cintia, Napoli, Italia.

出版信息

Nucleic Acids Res. 2011 Sep 1;39(17):7858-67. doi: 10.1093/nar/gkr522. Epub 2011 Jun 28.

DOI:10.1093/nar/gkr522
PMID:21715374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3177225/
Abstract

Aptamers are structured oligonucleotides that recognize molecular targets and can function as direct protein inhibitors. The best-known example is the thrombin-binding aptamer, TBA, a single-stranded 15-mer DNA that inhibits the activity of thrombin, the key enzyme of coagulation cascade. TBA folds as a G-quadruplex structure, as proved by its NMR structure. The X-ray structure of the complex between TBA and human α-thrombin was solved at 2.9-Å resolution, but did not provide details of the aptamer conformation and the interactions with the protein molecule. TBA is rapidly processed by nucleases. To improve the properties of TBA, a number of modified analogs have been produced. In particular, a modified TBA containing a 5'-5' polarity inversion site, mTBA, has higher stability and higher affinity toward thrombin with respect to TBA, although it has a lower inhibitory activity. We present the crystal structure of the thrombin-mTBA complex at 2.15-Å resolution; the resulting model eventually provides a clear picture of thrombin-aptamers interaction, and also highlights the structural bases of the different properties of TBA and mTBA. Our findings open the way for a rational design of modified aptamers with improved potency as anticoagulant drugs.

摘要

适体是一种能够识别分子靶标并能作为直接蛋白质抑制剂发挥作用的结构寡核苷酸。最著名的例子是凝血酶结合适体(TBA),它是一种 15 个碱基的单链 DNA,能够抑制凝血酶(凝血级联反应的关键酶)的活性。TBA 形成 G-四链体结构,这一点已被其 NMR 结构所证明。TBA 与人 α-凝血酶复合物的 X 射线结构在 2.9 Å 分辨率下得到解决,但没有提供适体构象和与蛋白质分子相互作用的细节。TBA 易被核酸酶降解。为了改善 TBA 的性质,已经产生了许多修饰的类似物。特别是,一种含有 5'-5'极性反转位点的修饰 TBA(mTBA),相对于 TBA 具有更高的稳定性和对凝血酶的亲和力,尽管其抑制活性较低。我们提出了凝血酶-mTBA 复合物的晶体结构,分辨率为 2.15 Å;最终的模型提供了一个清晰的凝血酶-适体相互作用的图像,并突出了 TBA 和 mTBA 不同性质的结构基础。我们的发现为设计具有改进抗凝活性的改良适体开辟了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7f/3177225/a704d0cc3346/gkr522f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7f/3177225/3fe32f4a05d0/gkr522f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7f/3177225/954294d564e3/gkr522f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7f/3177225/2414a0960a07/gkr522f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7f/3177225/c575bad4eddf/gkr522f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7f/3177225/297ed6aaa4b6/gkr522f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7f/3177225/a704d0cc3346/gkr522f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7f/3177225/3fe32f4a05d0/gkr522f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7f/3177225/954294d564e3/gkr522f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7f/3177225/2414a0960a07/gkr522f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7f/3177225/c575bad4eddf/gkr522f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7f/3177225/297ed6aaa4b6/gkr522f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7f/3177225/a704d0cc3346/gkr522f6.jpg

相似文献

1
Thrombin-aptamer recognition: a revealed ambiguity.凝血酶适配体识别:一种揭示的歧义。
Nucleic Acids Res. 2011 Sep 1;39(17):7858-67. doi: 10.1093/nar/gkr522. Epub 2011 Jun 28.
2
Crystallization and preliminary X-ray analysis of the complex of human alpha-thrombin with a modified thrombin-binding aptamer.人α-凝血酶与修饰的凝血酶结合适体复合物的结晶及初步X射线分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Aug 1;66(Pt 8):961-3. doi: 10.1107/S1744309110024632. Epub 2010 Jul 29.
3
Stability and binding properties of a modified thrombin binding aptamer.一种修饰的凝血酶结合适体的稳定性和结合特性
Biophys J. 2008 Jan 15;94(2):562-9. doi: 10.1529/biophysj.107.117382. Epub 2007 Sep 21.
4
High-resolution structures of two complexes between thrombin and thrombin-binding aptamer shed light on the role of cations in the aptamer inhibitory activity.两个凝血酶-凝血酶结合适体复合物的高分辨率结构揭示了阳离子在适体抑制活性中的作用。
Nucleic Acids Res. 2012 Sep;40(16):8119-28. doi: 10.1093/nar/gks512. Epub 2012 Jun 4.
5
Different duplex/quadruplex junctions determine the properties of anti-thrombin aptamers with mixed folding.不同的双链/四链连接决定了具有混合折叠的抗凝血酶适体的性质。
Nucleic Acids Res. 2016 Jan 29;44(2):983-91. doi: 10.1093/nar/gkv1384. Epub 2015 Dec 15.
6
Dissecting the contribution of thrombin exosite I in the recognition of thrombin binding aptamer.解析凝血酶外切位点 I 在识别凝血酶结合适体中的贡献。
FEBS J. 2013 Dec;280(24):6581-8. doi: 10.1111/febs.12561. Epub 2013 Nov 1.
7
Impact of the Position of the Chemically Modified 5-Furyl-2'-Deoxyuridine Nucleoside on the Thrombin DNA Aptamer-Protein Complex: Structural Insights into Aptamer Response from MD Simulations.化学修饰的 5-糠基-2'-脱氧尿苷核苷位置对凝血酶 DNA 适体-蛋白质复合物的影响:从 MD 模拟中对适体反应的结构见解。
Molecules. 2019 Aug 10;24(16):2908. doi: 10.3390/molecules24162908.
8
Improved thrombin binding aptamer analogues containing inversion of polarity sites: structural effects of extra-residues at the ends.含反转极性位点的改良凝血酶结合适体类似物:末端额外残基的结构效应。
Org Biomol Chem. 2016 Aug 10;14(32):7707-14. doi: 10.1039/c6ob00931j.
9
Crystal structures of thrombin in complex with chemically modified thrombin DNA aptamers reveal the origins of enhanced affinity.与化学修饰的凝血酶 DNA 适体复合物的凝血酶晶体结构揭示了增强亲和力的起源。
Nucleic Acids Res. 2018 May 18;46(9):4819-4830. doi: 10.1093/nar/gky268.
10
G-quadruplex-based aptamers targeting human thrombin: Discovery, chemical modifications and antithrombotic effects.基于 G-四链体的靶向人凝血酶适体:发现、化学修饰及抗血栓作用。
Pharmacol Ther. 2021 Jan;217:107649. doi: 10.1016/j.pharmthera.2020.107649. Epub 2020 Aug 7.

引用本文的文献

1
Investigating Protein-Nucleic Acid Binding Interactions with Diethylpyrocarbonate Covalent Labeling-Mass Spectrometry.利用二乙基焦碳酸酯共价标记-质谱法研究蛋白质-核酸相互作用。
J Am Soc Mass Spectrom. 2024 Oct 2;35(10):2272-2275. doi: 10.1021/jasms.4c00285. Epub 2024 Aug 29.
2
Comprehensive analysis of intramolecular G-quadruplex structures: furthering the understanding of their formalism.分子内G-四链体结构的综合分析:深化对其形式的理解。
Nucleic Acids Res. 2024 Apr 24;52(7):3522-3546. doi: 10.1093/nar/gkae182.
3
Structural Insights into Protein-Aptamer Recognitions Emerged from Experimental and Computational Studies.

本文引用的文献

1
[33] AMoRe: An automated molecular replacement program package.[33] AMoRe:一个自动分子置换程序包。
Methods Enzymol. 1997;276:581-594. doi: 10.1016/S0076-6879(97)76079-8.
2
Improved thrombin binding aptamer by incorporation of a single unlocked nucleic acid monomer.通过引入单个非锁定核酸单体来改善凝血酶结合适体。
Nucleic Acids Res. 2011 Feb;39(3):1155-64. doi: 10.1093/nar/gkq823. Epub 2010 Sep 24.
3
Crystallization and preliminary X-ray analysis of the complex of human alpha-thrombin with a modified thrombin-binding aptamer.
从实验和计算研究中揭示出蛋白-适体识别的结构见解。
Int J Mol Sci. 2023 Nov 14;24(22):16318. doi: 10.3390/ijms242216318.
4
The Influence of Chirality on the β-Amino-Acid Naphthalenediimides/G-Quadruplex DNA Interaction.手性对 β-氨基酸萘二酰亚胺/G-四链体 DNA 相互作用的影响。
Molecules. 2023 Oct 27;28(21):7291. doi: 10.3390/molecules28217291.
5
Improving the Biological Properties of Thrombin-Binding Aptamer by Incorporation of 8-Bromo-2'-Deoxyguanosine and 2'-Substituted RNA Analogues.通过整合 8-溴-2'-脱氧鸟苷和 2'-取代的 RNA 类似物来改善凝血酶结合适体的生物学特性。
Int J Mol Sci. 2023 Oct 24;24(21):15529. doi: 10.3390/ijms242115529.
6
A terminal functionalization strategy reveals unusual binding abilities of anti-thrombin anticoagulant aptamers.一种末端功能化策略揭示了抗凝血酶抗凝适体不同寻常的结合能力。
Mol Ther Nucleic Acids. 2022 Nov 15;30:585-594. doi: 10.1016/j.omtn.2022.11.007. eCollection 2022 Dec 13.
7
Solution structure of a thrombin binding aptamer complex with a non-planar platinum(ii) compound.凝血酶结合适体与非平面铂(II)化合物复合物的溶液结构
Chem Sci. 2022 Jun 23;13(28):8371-8379. doi: 10.1039/d2sc01196d. eCollection 2022 Jul 20.
8
The role of DNA nanostructures in the catalytic properties of an allosterically regulated protease.DNA纳米结构在变构调节蛋白酶催化特性中的作用。
Sci Adv. 2022 Jan 7;8(1):eabk0425. doi: 10.1126/sciadv.abk0425. Epub 2022 Jan 5.
9
A Comprehensive Analysis of the Thrombin Binding Aptamer Containing Functionalized Pyrrolo-2'-deoxycytidines.含功能化吡咯并-2'-脱氧胞苷的凝血酶结合适体的综合分析
Pharmaceuticals (Basel). 2021 Dec 18;14(12):1326. doi: 10.3390/ph14121326.
10
Exosite Binding in Thrombin: A Global Structural/Dynamic Overview of Complexes with Aptamers and Other Ligands.凝血酶的外切位点结合:适体和其他配体复合物的整体结构/动力学概述。
Int J Mol Sci. 2021 Oct 6;22(19):10803. doi: 10.3390/ijms221910803.
人α-凝血酶与修饰的凝血酶结合适体复合物的结晶及初步X射线分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Aug 1;66(Pt 8):961-3. doi: 10.1107/S1744309110024632. Epub 2010 Jul 29.
4
Combinatorial synthesis of thrombin-binding aptamers containing iso-guanine.含异鸟嘌呤的凝血酶结合适体的组合合成
J Comb Chem. 2009 May-Jun;11(3):364-9. doi: 10.1021/cc800178m.
5
Nucleotide-derived thrombin inhibitors: a new tool for an old issue.核苷酸衍生的凝血酶抑制剂:解决老问题的新工具。
Cardiovasc Hematol Agents Med Chem. 2009 Jan;7(1):19-28. doi: 10.2174/187152509787047658.
6
HBAT: a complete package for analysing strong and weak hydrogen bonds in macromolecular crystal structures.HBAT:用于分析大分子晶体结构中强氢键和弱氢键的完整程序包。
In Silico Biol. 2007;7(6):651-61.
7
Stability and binding properties of a modified thrombin binding aptamer.一种修饰的凝血酶结合适体的稳定性和结合特性
Biophys J. 2008 Jan 15;94(2):562-9. doi: 10.1529/biophysj.107.117382. Epub 2007 Sep 21.
8
A new modified thrombin binding aptamer containing a 5'-5' inversion of polarity site.一种新的修饰凝血酶结合适体,其含有一个5'-5'极性反转位点。
Nucleic Acids Res. 2006;34(22):6653-62. doi: 10.1093/nar/gkl915. Epub 2006 Dec 1.
9
Structure of the human telomere in K+ solution: an intramolecular (3 + 1) G-quadruplex scaffold.钾离子溶液中人类端粒的结构:一种分子内(3 + 1)G-四链体支架
J Am Chem Soc. 2006 Aug 2;128(30):9963-70. doi: 10.1021/ja062791w.
10
Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution.在钾溶液中,人类端粒序列形成一种具有混合平行/反平行链的杂合型分子内G-四链体结构。
Nucleic Acids Res. 2006 May 19;34(9):2723-35. doi: 10.1093/nar/gkl348. Print 2006.